These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28367951)

  • 1. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.
    Nobili A; Latagliata EC; Viscomi MT; Cavallucci V; Cutuli D; Giacovazzo G; Krashia P; Rizzo FR; Marino R; Federici M; De Bartolo P; Aversa D; Dell'Acqua MC; Cordella A; Sancandi M; Keller F; Petrosini L; Puglisi-Allegra S; Mercuri NB; Coccurello R; Berretta N; D'Amelio M
    Nat Commun; 2017 Apr; 8():14727. PubMed ID: 28367951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease.
    Cordella A; Krashia P; Nobili A; Pignataro A; La Barbera L; Viscomi MT; Valzania A; Keller F; Ammassari-Teule M; Mercuri NB; Berretta N; D'Amelio M
    Neurobiol Dis; 2018 Aug; 116():142-154. PubMed ID: 29778899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice.
    Jing MY; Han X; Zhao TY; Wang ZY; Lu GY; Wu N; Song R; Li J
    Metab Brain Dis; 2019 Oct; 34(5):1421-1430. PubMed ID: 31313126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans.
    D'Amelio M; Serra L; Bozzali M
    J Alzheimers Dis; 2018; 63(1):181-183. PubMed ID: 29630556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Ca
    La Barbera L; Nobili A; Cauzzi E; Paoletti I; Federici M; Saba L; Giacomet C; Marino R; Krashia P; Melone M; Keller F; Mercuri NB; Viscomi MT; Conti F; D'Amelio M
    Mol Neurodegener; 2022 Nov; 17(1):76. PubMed ID: 36434727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.
    Loureiro M; Renard J; Zunder J; Laviolette SR
    Neuropsychopharmacology; 2015 May; 40(6):1436-47. PubMed ID: 25510937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model.
    Spoleti E; Krashia P; La Barbera L; Nobili A; Lupascu CA; Giacalone E; Keller F; Migliore M; Renzi M; D'Amelio M
    Exp Neurol; 2022 Apr; 350():113969. PubMed ID: 34973962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
    Spoleti E; La Barbera L; Cauzzi E; De Paolis ML; Saba L; Marino R; Sciamanna G; Di Lazzaro V; Keller F; Nobili A; Krashia P; D'Amelio M
    Mol Psychiatry; 2024 May; 29(5):1265-1280. PubMed ID: 38228889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease.
    Vorobyov V; Bakharev B; Medvinskaya N; Nesterova I; Samokhin A; Deev A; Tatarnikova O; Ustyugov AA; Sengpiel F; Bobkova N
    J Alzheimers Dis; 2019; 70(1):241-256. PubMed ID: 31177214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.
    Steele JW; Brautigam H; Short JA; Sowa A; Shi M; Yadav A; Weaver CM; Westaway D; Fraser PE; St George-Hyslop PH; Gandy S; Hof PR; Dickstein DL
    J Comp Neurol; 2014 Jul; 522(10):2319-35. PubMed ID: 24415002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease.
    La Barbera L; Vedele F; Nobili A; Krashia P; Spoleti E; Latagliata EC; Cutuli D; Cauzzi E; Marino R; Viscomi MT; Petrosini L; Puglisi-Allegra S; Melone M; Keller F; Mercuri NB; Conti F; D'Amelio M
    Prog Neurobiol; 2021 Jul; 202():102031. PubMed ID: 33684513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective loss of dopaminergic neurons in the substantia nigra pars compacta after systemic administration of MPTP facilitates extinction learning.
    Kinoshita K; Tada Y; Muroi Y; Unno T; Ishii T
    Life Sci; 2015 Sep; 137():28-36. PubMed ID: 26209139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ninjin'yoeito on the electrophysiological properties of dopamine neurons in the ventral tegmental area/substantia nigra pars compacta and medium spiny neurons in the nucleus accumbens.
    Imai R; Mizuno K; Omiya Y; Mizoguchi K; Maejima Y; Shimomura K
    Aging (Albany NY); 2022 Jun; 14(11):4634-4652. PubMed ID: 35660668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
    Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
    Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.
    Kärkkäinen E; Yavich L; Miettinen PO; Tanila H
    Brain Res; 2015 Oct; 1622():452-65. PubMed ID: 26168899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human substantia nigra and ventral tegmental area. A neuroanatomical study with notes on aging and aging diseases.
    van Domburg PH; ten Donkelaar HJ
    Adv Anat Embryol Cell Biol; 1991; 121():1-132. PubMed ID: 2053466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.